|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.48 USD | -2.33% |
|
-20.05% | -30.89% |
| 12-10 | Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says | MT |
| 12-08 | UBS Adjusts Legend Biotech Price Target to $48 From $54, Maintains Buy Rating | MT |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















